Skip to content

The Effect of Photobiomodulation Using Low-Level Diode Laser Therapy on Postoperative Pain in Symptomatic Lower Molar Teeth With Irreversible Pulpitis and Apical Periodontitis; a Randomized Controlled Clinical Trial

The Effect of Photobiomodulation Using Low-Level Diode Laser Therapy on Postoperative Pain in Symptomatic Lower Molar Teeth With Irreversible Pulpitis and Apical Periodontitis; a Randomized Controlled Clinical Trial

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06396130
Enrollment
30
Registered
2024-05-02
Start date
2024-06-20
Completion date
2025-05-29
Last updated
2024-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Effect of Photobiomodulation Using Diode Laser

Brief summary

this study aims to assess the effect of photobiomodulation using low-level diode laser therapy on postoperative pain after single-visit root canal treatment of mandibular molars with symptomatic irreversible pulpitis and apical periodontitis.

Interventions

DEVICEPhotobiomodulation by low level diode laser

Diode laser exposure (Lite Medics 1.00-Watt serial number 148 Ver. SwvM. 150VS108VT.100) will be carried out using a continuous mode with 10 Hz frequency, 980 nm wavelength, and max power 15 WCW. The tip will be applied both at the buccal and the lingual side for 30 s each.

OTHERMock Laser Application

Placebo for control group

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* . Mature multirooted mandibular molar teeth with: i. Pre-operative sharp pain marked on the VAS scale by reading not less than 6. ii. Clinical diagnosis of symptomatic irreversible pulpitis with periapical periodontitis. iii. Normal periapical radiographic appearance or slight widening in lamina dura. iv. Positive response and pain provoked by percussion. \- Patients who agree to provide written consent and attend for recall appointments.

Exclusion criteria

* Patients who used NSAIDs in the 24 hours before treatment. * Medically compromised patients having significant systemic disorders. (ASA III or IV). * Patients with two or more adjacent teeth requiring endodontic treatment. * Pregnant or nursing females. 5. Teeth that have: i. Periodontal affection (with pocket depth greater than 5mm, associated with swelling orfistulous tract, or greater than grade I mobility). ii. No possible restorability. iii. Signs of pulpal necrosis; associated sinus tract or swelling.

Design outcomes

Primary

MeasureTime frameDescription
Intensity of postoperative pain24, 48 and 72 hoursUsing modified VAS

Secondary

MeasureTime frameDescription
Total number of analgesic tablets taken in case of intolerable painPost instrumentation at 24, 48 and 72 hoursCounted and recorded by the patient on a special table.

Contacts

Primary ContactNour ElGendi, Bds
nour.elgendi@dentistry.cu.edu.eg01001753319

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026